New Animal Drugs; Change of Sponsor's Name, 35174 [05-11928]
Download as PDF
<![CDATA[
35174
Federal Register / Vol. 70, No. 116 / Friday, June 17, 2005 / Rules and Regulations
Alert Service Bulletin A84–26–06, dated May
12, 2005.
Unsafe Condition
(d) This AD was prompted by reports of the
electrical connectors for the fire bottles in the
forward and aft compartments being cross
connected. The FAA is issuing this AD to
detect and correct cross connection of the fire
extinguisher bottles, which could result in
failure of the fire bottles to discharge and
consequent inability to extinguish a fire in
the affected areas.
Issued in Renton, Washington, on June 7,
2005.
Michael J. Kaszycki,
Acting Manager, Transport Airplane
Directorate, Aircraft Certification Service.
[FR Doc. 05–11792 Filed 6–16–05; 8:45 am]
BILLING CODE 4910–13–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Compliance
Food and Drug Administration
(e) You are responsible for having the
actions required by this AD performed within
the compliance times specified, unless the
actions have already been done.
21 CFR Part 510
Inspection and Corrective Action
(f) Within 14 days after the effective date
of this AD, inspect the electrical connectors
of the fire extinguisher bottles for the forward
and aft baggage compartments and for the
auxiliary power unit and engine nacelles to
determine if they are connected correctly;
and, before further flight, do the related
investigative and corrective actions, as
applicable; by doing all of the applicable
actions specified in the Accomplishment
Instructions of Bombardier Alert Service
Bulletin A84–26–06, dated May 12, 2005.
Although the service bulletin referenced in
this AD specifies to submit certain
information to the manufacturer, this AD
does not include that requirement.
Alternative Methods of Compliance
(AMOCs)
(g) The Manager, New York Aircraft
Certification Office, FAA, has the authority to
approve AMOCs for this AD, if requested in
accordance with the procedures found in 14
CFR 39.19.
Related Information
(h) Canadian airworthiness directive CF–
2005–14, dated May 16, 2005, also addresses
the subject of this AD.
Material Incorporated by Reference
(i) You must use Bombardier Alert Service
Bulletin A84–26–06, dated May 12, 2005, to
perform the actions that are required by this
AD, unless the AD specifies otherwise. The
Director of the Federal Register approves the
incorporation by reference of this document
in accordance with 5 U.S.C. 552(a) and 1 CFR
part 51. To get copies of the service
information, contact Bombardier, Inc.,
Bombardier Regional Aircraft Division, 123
Garratt Boulevard, Downsview, Ontario M3K
1Y5, Canada. To view the AD docket, go to
the Docket Management Facility, U.S.
Department of Transportation, 400 Seventh
Street SW., room PL–401, Nassif Building,
Washington, DC. To review copies of the
service information, go to the National
Archives and Records Administration
(NARA). For information on the availability
of this material at the NARA, call (202) 741–
6030, or go to https://www.archives.gov/
federal_register/code_of_federal_regulations/
ibr_locations.html.
VerDate jul<14>2003
14:16 Jun 16, 2005
Jkt 205001
New Animal Drugs; Change of
Sponsor’s Name
AGENCY:
[Amended]
2. Section 510.600 is amended in the
table in paragraph (c)(1) in the entry for
‘‘Rhodia Limited’’ by removing ‘‘Rhodia
Limited’’ and by adding in its place
‘‘Rhodia UK Limited’’, and in the table
in paragraph (c)(2) in the entry for
‘‘059258’’ by removing ‘‘Rhodia
Limited’’ and by adding in its place
‘‘Rhodia UK Limited’’.
I
Dated: June 8, 2005.
Steven D. Vaughn,
Director, Office of New Animal Drug
Evaluation, Center for Veterinary Medicine.
[FR Doc. 05–11928 Filed 6–16–05; 8:45 am]
BILLING CODE 4160–01–S
Food and Drug Administration,
HHS.
ACTION:
§510.600
ENVIRONMENTAL PROTECTION
AGENCY
Final rule.
SUMMARY: The Food and Drug
Administration (FDA) is amending the
animal drug regulations to reflect a
change of sponsor’s name from Rhodia
Limited to Rhodia UK Limited.
DATES: This rule is effective June 17,
2005.
FOR FURTHER INFORMATION CONTACT:
David R. Newkirk, Center for Veterinary
Medicine (HFV–100), Food and Drug
Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301–827–6967,
e-mail: david.newkirk@fda.gov.
SUPPLEMENTARY INFORMATION: Rhodia
Limited, P.O. Box 46, St. Andrews Rd.,
Avonmouth, Bristol BS11 9YF, England,
UK, has informed FDA of a change of
sponsor’s name to Rhodia UK Limited.
Accordingly, the agency is amending
the regulations in 21 CFR 510.600(c) to
reflect the change.
This rule does not meet the definition
of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because
it is a rule of ‘‘particular applicability.’’
Therefore, it is not subject to the
congressional review requirements in 5
U.S.C. 801–808.
40 CFR Part 300
[FRL–7924–5]
National Oil and Hazardous
Substances Pollution Contingency
Plan National Priorities List
Environmental Protection
Agency.
ACTION: Direct final notice of deletion of
Metropolitan Mirror and Glass (MM&G)
Superfund Site from the National
Priorities List.
AGENCY:
SUMMARY: The Environmental Protection
Agency (EPA) Region 3 is publishing a
direct final notice of deletion of the
MM&G, Superfund Site (Site), located in
Frackville, Schuylkill County,
Commonwealth of Pennsylvania, from
the National Priorities List (NPL).
The NPL, promulgated pursuant to
section 105 of the Comprehensive
Environmental Response,
Compensation, and Liability Act
(CERCLA) of 1980, as amended, is
appendix B of 40 CFR part 300, which
is the National Oil and Hazardous
List of Subjects in 21 CFR Part 510
Substances Pollution Contingency Plan
Administrative practice and
(NCP). This direct final deletion is being
procedure, Animal drugs, Labeling,
published by EPA with concurrence of
Reporting and recordkeeping
the Commonwealth of Pennsylvania,
requirements.
through the Pennsylvania Department of
I Therefore, under the Federal Food,
Environmental Protection (PADEP),
Drug, and Cosmetic Act and under
because EPA has determined that all
authority delegated to the Commissioner
appropriate response actions under
of Food and Drugs and redelegated to the
CERCLA have been completed and,
Center for Veterinary Medicine, 21 CFR
therefore, further remedial action
part 510 is amended as follows:
pursuant to CERCLA is not appropriate.
DATES: This direct final deletion will be
PART 510—NEW ANIMAL DRUGS
effective August 16, 2005 unless EPA
I 1. The authority citation for 21 CFR
receives adverse comments by July 18,
part 510 continues to read as follows:
2005. If adverse comments are received,
EPA will publish a timely withdrawal of
Authority: 21 U.S.C. 321, 331, 351, 352,
the direct final deletion in the Federal
353, 360b, 371, 379e.
PO 00000
Frm 00012
Fmt 4700
Sfmt 4700
E:\FR\FM\17JNR1.SGM
17JNR1
]]>Agencies
[Federal Register Volume 70, Number 116 (Friday, June 17, 2005)]
[Rules and Regulations]
[Page 35174]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-11928]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 510
New Animal Drugs; Change of Sponsor's Name
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect a change of sponsor's name from Rhodia
Limited to Rhodia UK Limited.
DATES: This rule is effective June 17, 2005.
FOR FURTHER INFORMATION CONTACT: David R. Newkirk, Center for
Veterinary Medicine (HFV-100), Food and Drug Administration, 7500
Standish Pl., Rockville, MD 20855, 301-827-6967, e-mail:
david.newkirk@fda.gov.
SUPPLEMENTARY INFORMATION: Rhodia Limited, P.O. Box 46, St. Andrews
Rd., Avonmouth, Bristol BS11 9YF, England, UK, has informed FDA of a
change of sponsor's name to Rhodia UK Limited. Accordingly, the agency
is amending the regulations in 21 CFR 510.600(c) to reflect the change.
This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements
in 5 U.S.C. 801-808.
List of Subjects in 21 CFR Part 510
Administrative practice and procedure, Animal drugs, Labeling,
Reporting and recordkeeping requirements.
0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is
amended as follows:
PART 510--NEW ANIMAL DRUGS
0
1. The authority citation for 21 CFR part 510 continues to read as
follows:
Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.
Sec. 510.600 [Amended]
0
2. Section 510.600 is amended in the table in paragraph (c)(1) in the
entry for ``Rhodia Limited'' by removing ``Rhodia Limited'' and by
adding in its place ``Rhodia UK Limited'', and in the table in
paragraph (c)(2) in the entry for ``059258'' by removing ``Rhodia
Limited'' and by adding in its place ``Rhodia UK Limited''.
Dated: June 8, 2005.
Steven D. Vaughn,
Director, Office of New Animal Drug Evaluation, Center for Veterinary
Medicine.
[FR Doc. 05-11928 Filed 6-16-05; 8:45 am]
BILLING CODE 4160-01-S
